Acadian Asset Management’s F-star Therapeutics FSTX Stock Holding History
Bought
Maintained
Sold
Other funds holding FSTX
Acadian Asset Management's FSTX Position: Q2 2021 in Review
Acadian Asset Management sold out of F-star Therapeutics (FSTX) in Q2 2021, closing a stake of 2,451 shares — an estimated $27K sold.
Acadian Asset Management first reported a position in FSTX in Q2 2019 and held it in 8 quarters. The position peaked at $49K in Q2 2020. 41 funds tracked by Wall St. Rank hold FSTX as of Q2 2021.
- Acadian Asset Management reported no remaining F-star Therapeutics position as of Q2 2021 after selling out during the quarter.
- Acadian Asset Management sold 2,451 F-star Therapeutics shares in Q2 2021, an estimated $27K.
- Acadian Asset Management first reported a position in F-star Therapeutics in Q2 2019 and held it in 8 quarters.
- Acadian Asset Management's F-star Therapeutics position peaked at $49K in Q2 2020.
- 41 funds tracked by Wall St. Rank held F-star Therapeutics as of Q2 2021.
Based on Acadian Asset Management's 13F filing for Q2 2021, filed 11 Aug 2021.